Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Hepatitis C

  Free Subscription


Articles published in Proc Natl Acad Sci U S A

Retrieve available abstracts of 26 articles:
HTML format



Single Articles


    July 2021
  1. DENG L, Hernandez N, Zhong L, Holcomb DD, et al
    A conserved epitope III on hepatitis C virus E2 protein has alternate conformations facilitating cell binding or virus neutralization.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    June 2021
  2. HIRANO J, Yoshio S, Sakai Y, Songling L, et al
    Hepatitis C virus modulates signal peptide peptidase to alter host protein processing.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    April 2021
  3. LOPEZ ANGEL CJ, Pham EA, Du H, Vallania F, et al
    Signatures of immune dysfunction in HIV and HCV infection share features with chronic inflammation in aging and persist after viral reduction or elimination.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    March 2021
  4. KIM GW, Siddiqui A
    N6-methyladenosine modification of HCV RNA genome regulates cap-independent IRES-mediated translation via YTHDC2 recognition.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    January 2021
  5. GUEST JD, Wang R, Elkholy KH, Chagas A, et al
    Design of a native-like secreted form of the hepatitis C virus E1E2 heterodimer.
    Proc Natl Acad Sci U S A. 2021;118.
    PubMed     Abstract available


    May 2020
  6. VERMA M, Chu JN, Salama JAF, Faiz MT, et al
    Development of a long-acting direct-acting antiviral system for hepatitis C virus treatment in swine.
    Proc Natl Acad Sci U S A. 2020 May 18. pii: 2004746117.
    PubMed     Abstract available


    April 2019
  7. PRENTOE J, Velazquez-Moctezuma R, Augestad EH, Galli A, et al
    Hypervariable region 1 and N-linked glycans of hepatitis C regulate virion neutralization by modulating envelope conformations.
    Proc Natl Acad Sci U S A. 2019 Apr 30. pii: 1822002116.
    PubMed     Abstract available


    January 2019
  8. WILSON DJ
    The harmonic mean p-value for combining dependent tests.
    Proc Natl Acad Sci U S A. 2019;116:1195-1200.
    PubMed     Abstract available


  9. PETHE MA, Rubenstein AB, Khare SD
    Data-driven supervised learning of a viral protease specificity landscape from deep sequencing and molecular simulations.
    Proc Natl Acad Sci U S A. 2019;116:168-176.
    PubMed     Abstract available


    December 2018
  10. FURUSE Y
    Analysis of research intensity on infectious disease by disease burden reveals which infectious diseases are neglected by researchers.
    Proc Natl Acad Sci U S A. 2018 Dec 31. pii: 1814484116.
    PubMed     Abstract available


    July 2018
  11. KINCAID RP, Lam VL, Chirayil RP, Randall G, et al
    RNA triphosphatase DUSP11 enables exonuclease XRN-mediated restriction of hepatitis C virus.
    Proc Natl Acad Sci U S A. 2018 Jul 23. pii: 1802326115.
    PubMed     Abstract available


  12. KE R, Li H, Wang S, Ding W, et al
    Superinfection and cure of infected cells as mechanisms for hepatitis C virus adaptation and persistence.
    Proc Natl Acad Sci U S A. 2018 Jul 9. pii: 1805267115.
    PubMed     Abstract available


    June 2018
  13. ALEMAN F, Tzarum N, Kong L, Nagy K, et al
    Immunogenetic and structural analysis of a class of HCV broadly neutralizing antibodies and their precursors.
    Proc Natl Acad Sci U S A. 2018 Jun 28. pii: 1802378115.
    PubMed     Abstract available


    December 2017
  14. MANKOWSKI MC, Kinchen VJ, Wasilewski LN, Flyak AI, et al
    Synergistic anti-HCV broadly neutralizing human monoclonal antibodies with independent mechanisms.
    Proc Natl Acad Sci U S A. 2017 Dec 18. pii: 1718441115.
    PubMed     Abstract available



  15. Correction for Giang et al., Human broadly neutralizing antibodies to the envelope glycoprotein complex of hepatitis C virus.
    Proc Natl Acad Sci U S A. 2017 Dec 11. pii: 1720228115.
    PubMed    


    November 2017
  16. HIRANO J, Okamoto T, Sugiyama Y, Suzuki T, et al
    Characterization of SPP inhibitors suppressing propagation of HCV and protozoa.
    Proc Natl Acad Sci U S A. 2017 Nov 29. pii: 1712484114.
    PubMed     Abstract available


    May 2017
  17. PADMANABHAN P, Dixit NM
    Inhibitors of hepatitis C virus entry may be potent ingredients of optimal drug combinations.
    Proc Natl Acad Sci U S A. 2017 May 16. pii: 201704531.
    PubMed    


  18. OHASHI H, Koizumi Y, Fukano K, Wakita T, et al
    Reply to Padmanabhan and Dixit: Hepatitis C virus entry inhibitors for optimally boosting direct-acting antiviral-based treatments.
    Proc Natl Acad Sci U S A. 2017 May 16. pii: 201705234.
    PubMed    


    April 2017
  19. HANSEN MD, Johnsen IB, Stiberg KA, Sherstova T, et al
    Hepatitis C virus triggers Golgi fragmentation and autophagy through the immunity-related GTPase M.
    Proc Natl Acad Sci U S A. 2017 Apr 7. pii: 201616683.
    PubMed     Abstract available


    March 2017

  20. Correction for Koizumi et al., Quantifying antiviral activity optimizes drug combinations against hepatitis C virus infection.
    Proc Natl Acad Sci U S A. 2017 Mar 6. pii: 201702625.
    PubMed    


    February 2017
  21. KOIZUMI Y, Ohashi H, Nakajima S, Tanaka Y, et al
    Quantifying antiviral activity optimizes drug combinations against hepatitis C virus infection.
    Proc Natl Acad Sci U S A. 2017 Feb 7. pii: 201610197.
    PubMed     Abstract available


  22. QI H, Chu V, Wu NC, Chen Z, et al
    Systematic identification of anti-interferon function on hepatitis C virus genome reveals p7 as an immune evasion protein.
    Proc Natl Acad Sci U S A. 2017 Feb 3. pii: 201614623.
    PubMed     Abstract available


    December 2016
  23. LIU WL, Yang HC, Hsu CS, Wang CC, et al
    Pegylated IFN-alpha suppresses hepatitis C virus by promoting the DAPK-mTOR pathway.
    Proc Natl Acad Sci U S A. 2016 Dec 6. pii: 201618517.
    PubMed     Abstract available


    October 2016
  24. PIERCE BG, Keck ZY, Lau P, Fauvelle C, et al
    Global mapping of antibody recognition of the hepatitis C virus E2 glycoprotein: Implications for vaccine design.
    Proc Natl Acad Sci U S A. 2016 Oct 26. pii: 201614942.
    PubMed     Abstract available


  25. KONG L, Lee DE, Kadam RU, Liu T, et al
    Structural flexibility at a major conserved antibody target on hepatitis C virus E2 antigen.
    Proc Natl Acad Sci U S A. 2016 Oct 24. pii: 201609780.
    PubMed     Abstract available


  26. WOZNIAK AL, Long A, Jones-Jamtgaard KN, Weinman SA, et al
    Hepatitis C virus promotes virion secretion through cleavage of the Rab7 adaptor protein RILP.
    Proc Natl Acad Sci U S A. 2016 Oct 17. pii: 201607277.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Hepatitis C is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: